Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.

Wnt5a is one of the so-called non-canonical Wnt ligands which do not act through β-catenin. In normal development, Wnt5a is secreted and directs the migration of target cells along concentration gradients. The effect of Wnt5a on target cells is regulated by many factors, including the expression lev...

Full description

Saved in:
Bibliographic Details
Main Authors: Celine Pourreyron, Louise Reilly, Charlotte Proby, Andrey Panteleyev, Colin Fleming, Kathleen McLean, Andrew P South, John Foerster
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0031827&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224571351826432
author Celine Pourreyron
Louise Reilly
Charlotte Proby
Andrey Panteleyev
Colin Fleming
Kathleen McLean
Andrew P South
John Foerster
author_facet Celine Pourreyron
Louise Reilly
Charlotte Proby
Andrey Panteleyev
Colin Fleming
Kathleen McLean
Andrew P South
John Foerster
author_sort Celine Pourreyron
collection DOAJ
description Wnt5a is one of the so-called non-canonical Wnt ligands which do not act through β-catenin. In normal development, Wnt5a is secreted and directs the migration of target cells along concentration gradients. The effect of Wnt5a on target cells is regulated by many factors, including the expression level of inhibitors and receptors. Dysregulated Wnt5a signalling facilitates invasion of multiple tumor types into adjacent tissue. However, the expression and distribution of Wnt5a in cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), as well as the effect of Wnt5a on keratinocyte migration has not been studied in detail to date. We here report that Wnt5a is upregulated in SCC and BCC and localised to the leading edge of tumors, as well as tumor-associated fibroblasts. The Wnt5a-triggered bundling of its receptor Fzd3 provides evidence of Wnt5a concentration gradients projecting into the tumor. In vitro migration assays show that Wnt5a concentration gradients determine its effect on keratinoctye migration: While chemotactic migration is inhibited by Wnt5a present in homogenous concentrations, it is enhanced in the presence of a Wnt5a gradient. Expression profiling of the Wnt pathway shows that the upregulation of Wnt5a in SCC is coupled to repression of canonical Wnt signalling. This is confirmed by immunohistochemistry showing lack of nuclear β-catenin, as well as absent accumulation of Axin2. Since both types of Wnt signalling act mutually antogonistically at multiple levels, the concurrent repression of canonical Wnt signalling suggests hyper-active Wnt5a signal transduction. Significantly, this combination of gene dysregulation is not observed in the benign hyperproliferative inflammatory skin disease psoriasis. Collectively, our data strongly suggest that Wnt5a signalling contributes to tissue invasion by non-melanoma skin cancer.
format Article
id doaj-art-ea70378103254655894ae32e272dbb47
institution OA Journals
issn 1932-6203
language English
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ea70378103254655894ae32e272dbb472025-08-20T02:05:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0172e3182710.1371/journal.pone.0031827Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.Celine PourreyronLouise ReillyCharlotte ProbyAndrey PanteleyevColin FlemingKathleen McLeanAndrew P SouthJohn FoersterWnt5a is one of the so-called non-canonical Wnt ligands which do not act through β-catenin. In normal development, Wnt5a is secreted and directs the migration of target cells along concentration gradients. The effect of Wnt5a on target cells is regulated by many factors, including the expression level of inhibitors and receptors. Dysregulated Wnt5a signalling facilitates invasion of multiple tumor types into adjacent tissue. However, the expression and distribution of Wnt5a in cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), as well as the effect of Wnt5a on keratinocyte migration has not been studied in detail to date. We here report that Wnt5a is upregulated in SCC and BCC and localised to the leading edge of tumors, as well as tumor-associated fibroblasts. The Wnt5a-triggered bundling of its receptor Fzd3 provides evidence of Wnt5a concentration gradients projecting into the tumor. In vitro migration assays show that Wnt5a concentration gradients determine its effect on keratinoctye migration: While chemotactic migration is inhibited by Wnt5a present in homogenous concentrations, it is enhanced in the presence of a Wnt5a gradient. Expression profiling of the Wnt pathway shows that the upregulation of Wnt5a in SCC is coupled to repression of canonical Wnt signalling. This is confirmed by immunohistochemistry showing lack of nuclear β-catenin, as well as absent accumulation of Axin2. Since both types of Wnt signalling act mutually antogonistically at multiple levels, the concurrent repression of canonical Wnt signalling suggests hyper-active Wnt5a signal transduction. Significantly, this combination of gene dysregulation is not observed in the benign hyperproliferative inflammatory skin disease psoriasis. Collectively, our data strongly suggest that Wnt5a signalling contributes to tissue invasion by non-melanoma skin cancer.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0031827&type=printable
spellingShingle Celine Pourreyron
Louise Reilly
Charlotte Proby
Andrey Panteleyev
Colin Fleming
Kathleen McLean
Andrew P South
John Foerster
Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
PLoS ONE
title Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
title_full Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
title_fullStr Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
title_full_unstemmed Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
title_short Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
title_sort wnt5a is strongly expressed at the leading edge in non melanoma skin cancer forming active gradients while canonical wnt signalling is repressed
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0031827&type=printable
work_keys_str_mv AT celinepourreyron wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT louisereilly wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT charlotteproby wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT andreypanteleyev wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT colinfleming wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT kathleenmclean wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT andrewpsouth wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed
AT johnfoerster wnt5aisstronglyexpressedattheleadingedgeinnonmelanomaskincancerformingactivegradientswhilecanonicalwntsignallingisrepressed